A NEW GENE THERAPY PARADIGM IN VIVO CRISPR ENGINEERING OF HEMATOPOIETIC NICHES FOR CANCER IMMUNOTHERAPY. FMHR. 2026;4(6):1756-1802. Accessed June 26, 2026. https://fmhr.net/index.php/fmhr/article/view/3230